Component A Approved Name (Name in Paper) |
Component A Type |
Component B Approved Name (Name in Paper) |
Component B Type |
Statistical Result |
Relationship Description |
Result Category (Positive/Negative)) |
MDD
|
syndrome |
SLC6A1 (SLC6A1) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
SMOX (SMOX) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
SNAP2 (SNAP2) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
SNAP23 (SNAP23) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
QKI (QKI) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
S100B (S100B) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
SAT1 (SAT) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
SLC1A2 (SLC1A2) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
LEPR (LEPR) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
PCDH9 (PCDH9) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
PRG3 (PRG-3) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
PTK2B (PTK2B) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GRIN2A (GRIN2A) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GCOM1 (GRINL1A) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GRM3 (GRM3) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
HTR2A (HTR2A) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GLUL (GLUL) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GABRR1 (GABRR1) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GRIA3 (GRIA3) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GPM6B (GPM6B) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GABRD (GABRD) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GABRB1 (GABRB1) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GABRG2 (GABRG2) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GABRG1 (GABRG1) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
CNTNAP3 (CNTNAP3) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
CAT (CAT) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GABRA5 (GABRA5) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
GABBR2 (GABBR2) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
ADRA2A (ADRA2A) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
AK4 (AK3L1) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
AK3 (AK3) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
YWHA (YWHA) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
VAMP3 (VAMP3) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
SYT13 (SYT13) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
SYPL1 (SYPL) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|
MDD
|
syndrome |
SYN2 (SYN2) |
gene |
|
Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) |
Positive
|